1163566003: Belumosudil (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Rho-associated protein kinase inhibitor\Belumosudil (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Belumosudil (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4597369018 Belumosudil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4597370017 Belumosudil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Belumosudil (substance)	Is a	Heterocyclic compound	true	Inferred relationship	Some
Belumosudil (substance)	Is a	Rho-associated protein kinase inhibitor	true	Inferred relationship	Some
Belumosudil (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Rho-associated protein kinase inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Belumosudil mesilate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Belumosudil (substance)	Inferred relationship	Some
Belumosudil-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Belumosudil (substance)	Inferred relationship	Some	1
Product containing only belumosudil in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Belumosudil (substance)	Inferred relationship	Some	1
Product containing belumosudil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Belumosudil (substance)	Inferred relationship	Some	1
Product containing only belumosudil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Belumosudil (substance)	Inferred relationship	Some	1
Product containing precisely belumosudil (as belumosudil mesilate) 200 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Belumosudil (substance)	Inferred relationship	Some	1

This concept is not in any reference sets